BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21484430)

  • 21. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
    Tsuji M; Kashihara T; Terada N; Mori H
    Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma.
    Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.
    Tsai TJ; Chao WY; Chen CC; Chen YJ; Lin CY; Lee YR
    Anticancer Res; 2018 Jul; 38(7):3943-3950. PubMed ID: 29970516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.
    Lazarevich NL; Cheremnova OA; Varga EV; Ovchinnikov DA; Kudrjavtseva EI; Morozova OV; Fleishman DI; Engelhardt NV; Duncan SA
    Hepatology; 2004 Apr; 39(4):1038-47. PubMed ID: 15057908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia.
    Miskad UA; Yano Y; Nakaji M; Kishi S; Itoh H; Kim SR; Ku Y; Kuroda Y; Hayashi Y
    Pathol Int; 2001 Dec; 51(12):916-22. PubMed ID: 11844063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
    Chang TM; Hung WC
    Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
    Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
    World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
    Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.
    Wang RC; Huang CY; Pan TL; Chen WY; Ho CT; Liu TZ; Chang YJ
    PLoS One; 2015; 10(10):e0139232. PubMed ID: 26431426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation.
    He Q; Huang W; Liu D; Zhang T; Wang Y; Ji X; Xie M; Sun M; Tian D; Liu M; Xia L
    Theranostics; 2021; 11(12):5759-5777. PubMed ID: 33897880
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of microRNAs regulating Hlxb9 gene expression during the induction of insulin-producing cells.
    Mu C; Wang T; Wang X; Tian H; Liu Y
    Cell Biol Int; 2016 May; 40(5):515-23. PubMed ID: 26801823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor.
    Jiang L; Wang X; Ma F; Wang X; Shi M; Yan Q; Liu M; Chen J; Shi C; Guan XY
    J Exp Clin Cancer Res; 2022 Jun; 41(1):211. PubMed ID: 35765089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
    Luan F; Liu P; Ma H; Yue X; Liu J; Gao L; Liang X; Ma C
    Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HOX gene network in hepatocellular carcinoma.
    Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
    Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-5692a promotes proliferation and inhibits apoptosis by targeting HOXD8 in hepatocellular carcinoma.
    Sun S; Wang N; Sun Z; Wang X; Cui H
    J BUON; 2019; 24(1):178-186. PubMed ID: 30941968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.